Skip to Main Content

Author Details

Arvin C Dar
2002
33
20
PMIDPaper TitleJournal TitlePublished Year
37537299WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma.Nat Cancer2023
37919548Live-cell target engagement of allosteric MEKi on MEK-RAF/KSR-14-3-3 complexes.2023
35244677Understanding and drugging RAS: 40â¿¿years to break the tip of the iceberg.DMM Disease Models and Mechanisms2022
35525547Conformational control and regulation of the pseudokinase KSR via small molecule binding interactions.Methods in Enzymology2022
35697804Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR.Nat Biotechnol2022
35726064Targeting drug-resistant mutations in ALK.Nature Cancer2022
36400004RASopathy mutations open new insights into the mechanism of BRAF activation.Molecular Cell2022
33440120Type II Binders Targeting the "GLR-Out" Conformation of the Pseudokinase STRADα.Biochemistry2021
32679092Ploidy Leads a Molecular Motor to Walk Different Paths to Drug Resistance.Cell Chemical Biology2020
32927473Structural basis for the action of the drug trametinib at KSR-bound MEK.Nature2020
31196969Regulated Phosphosignaling Associated with Breast Cancer Subtypes and Druggability.Mol Cell Proteomics2019
31026276Integrated computational and Drosophila cancer model platform captures previously unappreciated chemicals perturbing a kinase network.PLoS Comput Biol2019
31213506Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC Polypharmacology.Mol Cancer Ther2019
29355849A whole-animal platform to advance a clinical kinase inhibitor into new disease space.Nat Chem Biol2018
28718326CNS Anticancer Drug Discovery and Development: 2016 conference insights.CNS Oncol2017
27556948Small molecule stabilization of the KSR inactive state antagonizes oncogenic Ras signalling.Nature2016
25986605Endoplasmic reticulum stress-independent activation of unfolded protein response kinases by a small molecule ATP-mimic.Elife2015
26403167CNS Anticancer Drug Discovery and Development Conference White Paper.Neuro Oncol2015
25403145Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors.Nat Commun2014
23841803Structure-guided inhibitor design expands the scope of analog-sensitive kinase technology.ACS Chem Biol2013
23863168A pickup in pseudokinase activity.Biochemical Society Transactions2013
22678283Chemical genetic discovery of targets and anti-targets for cancer polypharmacology.Nature2012
21548788The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling.Annu Rev Biochem2011
21441910A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK.Nature2011
23836541Chemical genetic approach for kinase-substrate mapping by covalent capture of thiophosphopeptides and analysis by mass spectrometry.Curr Protoc Chem Biol2010
18940662Small molecule recognition of c-Src via the Imatinib-binding conformation.Chem Biol2008
18971339Protein kinase PKR mutants resistant to the poxvirus pseudosubstrate K3L protein.Proceedings of the National Academy of Sciences of the United States of America2008
16179258Higher-order substrate recognition of eIF2alpha by the RNA-dependent protein kinase PKR.Cell2005
15798194PKR and GCN2 kinases and guanine nucleotide exchange factor eukaryotic translation initiation factor 2B (eIF2B) recognize overlapping surfaces on eIF2alpha.Molecular and Cellular Biology2005
16179259Mechanistic link between PKR dimerization, autophosphorylation, and eIF2alpha substrate recognition.Cell2005
14561409Formin leaky cap allows elongation in the presence of tight capping proteins.Curr Biol2003
12191475X-ray crystal structure and functional analysis of vaccinia virus K3L reveals molecular determinants for PKR subversion and substrate recognition.Molecular Cell2002
12384601Slipped-strand DNAs formed by long (CAG)*(CTG) repeats: slipped-out repeats and slip-out junctions.Nucleic Acids Research2002
  • 1 - 33 of 33

Recommended Authors

Collaborators

University of California San Francisco
Co-authored papers 7
University of Glasgow
Co-authored papers 3
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Center for Epigenetics and Metabolism, University of California irvine
Co-authored papers 2
Co-authored papers 2
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 2
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Co-authored papers 1
Rockefeller University
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
University of Toronto
Co-authored papers 1
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Broad Institute of MIT and Harvard
Co-authored papers 1
Co-authored papers 1
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Co-authored papers 1
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Co-authored papers 1
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 1
Massachusetts Institute of Technology
Co-authored papers 1
University of California san francisco
Co-authored papers 1
McGill Research Centre for Studies in Aging
Co-authored papers 1
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Google Accelerated Science Team, Google Inc
Co-authored papers 1
Calico Life Sciences LLC
Co-authored papers 1
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 1